Korean Drug Market Cap

Korean Drug has a market cap or net worth of 46.32 billion as of April 29, 2026. Its market cap has decreased by -5.77% in one year.

Market Cap

46.32B

Enterprise Value

16.38B

Revenue

62.51B

Ranking

n/a

PE Ratio

7.11

Stock Price

4,230.00

Market Cap Chart

Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 46.32B, an increase of 269.39%. That is a compound annual growth rate of 6.39%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	46.32B	-1.28%
Dec 30, 2025	46.92B	-6.42%
Dec 30, 2024	50.14B	-36.00%
Dec 28, 2023	78.35B	-8.30%
Dec 29, 2022	85.44B	-12.32%
Dec 30, 2021	97.44B	-13.30%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HLscience	43.65B
GeneBioTech Co. ,Ltd	41.72B
Eagle Veterinary Technology Co.,Ltd	51.14B
RP Bio	54.60B
Korea Arlico Pharm	55.41B
Kyung Nam Pharm	60.10B
Seoul Pharma	33.75B
Jin Yang Pharmaceutical	62.10B

Market Cap Rankings